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Background: Depletion of mucosal Th17 cells during HIV/SIV infections is a major cause for microbial translocation,
chronic immune activation, and disease progression. Mechanisms contributing to Th17 deficit are not fully elucidated.
Here we investigated alterations in the Th17 polarization potential of naive-like CD4+ T-cells, depletion of Th17-commited
subsets during HIV pathogenesis, and Th17 restoration in response to antiretroviral therapy (ART).
Results: Peripheral blood CD4+ T-cells expressing a naive-like phenotype (CD45RA+CCR7+) from chronically HIV-infected
subjects receiving ART (CI on ART; median CD4 counts 592 cells/μl; viral load: <50 HIV-RNA copies/ml; time since
infection: 156 months) compared to uninfected controls (HIV-) were impaired in their survival and Th17 polarization
potential in vitro. In HIV- controls, IL-17A-producing cells mainly originated from naive-like T-cells with a regulatory
phenotype (nTregs: CD25highCD127−FoxP3+) and from CD25+CD127+FoxP3− cells (DP, double positive). Th17-polarized
conventional naive CD4+ T-cells (nT: CD25−CD127+FoxP3−) also produced IL17A, but at lower frequency compared to
nTregs and DP. In CI on ART subjects, the frequency/counts of nTreg and DP were significantly diminished compared
to HIV- controls, and this paucity was further associated with decreased proportions of memory T-cells producing IL-17A
and expressing Th17 markers (CCR6+CD26+CD161+, mTh17). nTregs and DP compared to nT cells harbored superior levels
of integrated/non-integrated HIV-DNA in CI on ART subjects, suggesting that permissiveness to integrative/abortive
infection contributes to impaired survival and Th17 polarization of lineage-committed cells. A cross-sectional study
in CI on ART subjects revealed that nTregs, DP and mTh17 counts were negatively correlated with the time post-infection
ART was initiated and positively correlated with nadir CD4 counts. Finally, a longitudinal analysis in a HIV primary infection
cohort demonstrated a tendency for increased nTreg, DP, and mTh17 counts with ART initiation during the first year of
infection.
Conclusions: These results support a model in which the paucity of phenotypically naive nTregs and DP cells, caused
by integrative/abortive HIV infection and/or other mechanisms, contributes to Th17 deficiency in HIV-infected subjects.
Early ART initiation, treatment intensification with integrase inhibitors, and/or other alternative interventions aimed at
preserving/restoring the pool of cells prone to acquire Th17 functions may significantly improve mucosal immunity in
HIV-infected subjects.
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HIV/SIV infections are associated with a massive deple-
tion of CD4+ T-cells from the gut-associated lymphoid
tissues (GALT), together with intestinal histological ab-
normalities characterized by epithelial cell apoptosis and
impaired mucosal barrier integrity [1-3]. Among CD4+
T-cells, Th17 cells are preferentially depleted from the
GALT of HIV-infected individuals with rapid disease
progression [4,5]. Th17 cell depletion from the GALT of
HIV-infected subjects and SIV-infected rhesus macaques
is considered to be a major cause for microbial transloca-
tion, chronic immune activation, and disease progression
[3,6-13]. The restoration of CD4+ T-cells in the GALT of
HIV-infected subjects receiving viral suppressive anti-
retroviral therapy (ART) is associated with an enhanced
frequency of Th17 cells and polyfunctional HIV-specific
T-cell responses [5,14,15]. However, the quantitative and
qualitative restoration of Th17 cells under long-term ART
is only partial in chronically infected subjects [5,8,14].
Very recent studies demonstrated that ART initiation dur-
ing the early acute phases of HIV infection (Fiebig I-II),
but not during the late acute and chronic phases, permits
the preservation of Th17 cell numbers/functions at mu-
cosal level [16]. The challenges of early HIV diagnosis
render immediate ART initiation almost utopic even in
high income countries.
Considering the critical role played by Th17 cells in
mucosal homeostasis [17-20] and HIV disease progres-
sion [16], understanding mechanisms of Th17 alterations
during HIV/SIV infections continues to be the focus of
active investigations. Studies by our group and others
demonstrated that memory Th17 cells are highly per-
missive to HIV infection in vitro and in vivo [8,21-25]
thus, implying a deleterious role of HIV infection per se
on Th17 cell survival. Other documented mechanisms
underlying Th17 deficiency during HIV/SIV infections in-
clude (i) altered trafficking potential of memory Th17 cells
into mucosal sites [26,27]; (ii) increased ratios between
regulatory T-cells versus Th17 cells at mucosal level due
to enhanced indoleamine 2,3-dioxygenase 1 (IDO)-medi-
ated tryptophan catabolism by mucosal dendritic cells
(DC) [28,29]; and/or (iii) depletion of mucosal CD103+
DC [30], a subset involved in Th17 differentiation [31,32].
The Th17 polarization of naive T-cells requires specific
signals via cytokines such as TGF-β, IL-6, IL-1β, and IL-
23 [33-35]. Levels of TGF-β [36], IL-6 [37], and IL-1 [38]
are documented to be upregulated during the course of
HIV-infection. IL-23 levels are upregulated during HIV
primary infection [39], but whether IL-23 production is al-
tered during the chronic phase of infection requires further
investigations [40,41]. One cytokine that appears to be lim-
iting is IL-21, a cytokine discovered to be involved in an al-
ternative Th17 differentiation pathway [42-44]. Our group
reported a deficit in IL-21 expression associated with HIVinfection, deficit that was partially restored by ART [45,46].
Decreased IL-21 levels were also reported during SIV in-
fection [47] and the administration of recombinant IL-21
led to the restoration/preservation of Th17 responses at
mucosal level in SIV-infected rhesus macaques [12]. Fi-
nally, the over expression of negative regulators implicated
in the inhibition of Th17 differentiation was linked to
Th17 deficiency in a SIV model of infection [48]. Together,
these advances reflect the complex and not fully elucidated
mechanisms underlying Th17 alterations during HIV/SIV
infections.
A fraction of human peripheral blood CD4+ T-cells ex-
pressing the naive markers CD45RA and CCR7 [49] and a
regulatory phenotype (nTregs: CD25highCD127−FoxP3+)
preferentially acquire Th17 features in vitro [35,50]. The
concept that nTregs include Th17-lineage committed cells
is consistent with the well documented differentiation re-
lationship between Th17 and Tregs [51,52] and in line
with the identification of suppressive Tregs that express
IL-17 (IL-17+ Tregs) [53]. The common origin of Tregs
and Th17 cells is further supported by very recent studies
in humans demonstrating the differentiation of IL-17-
producing effector and regulatory T-cells from phenotypic-
ally naive (CD45RO−) CCR6+FoxP3+Helios− CD4+ T-cells
[54,55]. Whether Th17 deficiency in HIV-infected subjects
is associated with the paucity of Th17-lineage committed
precursors remains unknown.
In this study, we investigated alterations in the Th17
polarization potential of phenotypically naive CD4+ T-
cells, sought to identify specific naive-like Th17-
commited T-cell subsets that are depleted during HIV
pathogenesis, and assessed the restoration of these sub-
sets in response to antiretroviral therapy (ART). Studies
were performed using peripheral blood samples col-
lected from recently HIV-infected untreated (RI) and
chronically infected aviremics under ART (CI on ART),
as well as longitudinal samples from HIV-infected sub-
jects with ART administered during the first year of in-
fection. Our results support a model in which the
paucity of phenotypically naive CD4+ T-cell subsets
enriched in Th17-lineage committed cells represents a
new mechanism contributing to Th17 deficiency in
chronically HIV-infected subjects receiving ART. New
therapeutic strategies such as early ART initiation and
treatment intensification with integrase inhibitors are
needed for the preservation of Th17 precursors and an
optimal restoration of mucosal immunity in HIV-
infected subjects.
Results
Phenotypically naive CD4+ T-cells from HIV-infected subjects
are impaired in their Th17 polarization potential in vitro
Mechanisms contributing to Th17 deficiency during HIV-1
infection are not fully elucidated. Here, we hypothesized
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erate new Th17 cells. To test this hypothesis, we investigated
the in vitro Th17 polarization potential of CD4+ T-cells
expressing the naive markers CD45RA and CCR7 [49] in
HIV-infected versus uninfected subjects. For this study,
large quantities of PBMCs were collected by leukapher-
esis from HIV-uninfected controls (HIV-; median CD4
counts: 852 cells/μl; Table 1) and two categories of HIV-
infected subjects: relatively recently infected viremics un-
treated (RI; median plasma viral load 14,454 HIV-RNA
copies/ml; median CD4 counts 455 cells/μl; median time
since infection 16 months; Table 2) and chronically in-
fected receiving viral suppressive ART (CI on ART;
plasma viral load <50 HIV-RNA copies/ml, median CD4
counts 592 cells/μl, and median time since infectionTable 1 Clinical parameters of HIV-negative subjects (HIV-)
Subjects CD4 counts1 CD8 counts1 Plasma viral load2
01 1,047 430 -
02 1,424 605 -
03 732 281 -
05 989 582 -
07 1,030 340 -
09 998 312 -
10 675 208 -
11 n.a. n.a. -
12 n.a. n.a. -
13 n.a. n.a. -
14 733 169 -
15 925 272 -
16 665 276 -
17 731 308 -
18 1,030 383 -
19 634 346 -
20 1,115 545 -
21 980 448 -
22 620 339 -
23 854 492 -
24 1,400 678 -
25 918 641 -
26 665 276 -
27 521 331 -
28 1,030 383 -
29 850 412 -
30 918 641 -
31 n.a. n.a. -
32 n.a. n.a. -
Median 918 364 -
1, cells/μl; 2, HIV RNA copies per ml plasma (log10);
3, months; ART, antiretroviral the156 months; Table 3). Highly pure phenotypically naive
(CD45RA+CCR7+) CD4+ T-cells were sorted by mag-
netic and then flow cytometry sorting (Additional file 1:
Figure S1). Cells were cultured under Th17 polarizing
conditions (TGF-β, IL-6, IL-1β, IL-23, and IL-2 recom-
binant cytokines and anti-IFN-γ and anti-IL-4 Abs) for
12 days (Figure 1A), using a differentiation protocol
adapted from reports by other groups [33-35]. Th17-
polarized cells were analyzed for the intracellular expres-
sion of IL-17A, IFN-γ, and TNF-α upon PMA/Ionomycin
stimulation in the presence of Brefeldin A. The major-
ity of Th17-polarized cells from both HIV- and CI on
ART subjects expressed IL-17A in the absence of IFN-γ
(IL-17A+IFN-γ−) but the presence of TNF-α (IL-17A+
TNF-α+), while only very small fractions of cells wereTime since infection3 ART ART initiation4 Age5
- - - 57
- - - 44
- - - 51
- - - 58
- - - 37
- - - 51
- - - 62
- - - 51
- - - 62
- - - 40
- - - 45
- - - 56
- - - 44
- - - 58
- - - 48
- - - 68
- - - 65
- - - 53
- - - 49
- - - 34
- - - 39
- - - 30
- - - 36
- - - 21
- - - 49
- - - 45
- - - 46
- - - 24
- - - 48
48
rapy; 4, months post-infection; 5, years; n.a., information not available.
Table 2 Clinical parameters of recently HIV-infected (RI) untreated subjects
Subjects CD4 counts1 CD8 counts1 Plasma viral load2 Time since infection3 ART ART initiation4 Age5
RI 01 510 491 958,435 3 No No 43
RI 02 571 1,266 5,897 7 No No 23
RI 03 310 350 200,363 42 No No 48
RI 04 443 551 5,551 16 No No 26
RI 05 345 931 318,611 34 No No 42
RI 06 368 251 5,766 6 No No 47
RI 07 333 628 206,719 9 No No 34
RI 08 676 1,524 20,893 7 No No 31
RI 09 478 495 4,898 12 No No 30
RI 10 665 804 5,012 24 No No 30
RI 11 397 622 14,454 23 No No 58
RI 12 499 531 9,772 13 No No 42
RI 13 435 1,274 36,308 24 No No 31
RI 14 468 765 151,356 25 No No 49
RI 15 455 365 5,370 24 No No 40
Median 455 622 14,454 16 No No 40
1, cells/μl; 2, HIV RNA copies per ml plasma (log10);
3, months; ART, antiretroviral therapy; 4, months post-infection; 5, years.














CI 01 463 36 757 50 152 3TC-Efavirenz 105 52
CI 02 n.a. 350 n.a. 50 94 Kivexa-Efavirenz 24 30
CI 03 616 486 330 40 186 Truvada-Viracept 153 29
CI 04 651 219 409 40 76 Kivexa-Nevirapine 19 39
CI 05 358 231 283 40 155 Atripla 142 48
CI 06 748 20 964 40 165 Truvada-Norvir-
Reyataz
134 50
CI 07 517 223 259 40 82 Kivexa-Sustiva 39 35
CI 08 269 263 282 50 n.a. n.a. n.a. 47
CI 09 569 299 462 50 111 Darunavir-Raltegravir 105 50
CI 10 391 181 620 50 165 Dalavirdine-Kivexa 34 46
CI 11 847 110 944 40 168 Reyataz-Kivexa 116 62
CI 12 498 201 531 40 213 Darunavir-Raltegravir-
Intelence-Ritonavir
155 62
CI 13 833 486 445 40 213 Truvada-Isentress 212 31
CI 14 886 301 579 40 60 Truvada-Isentress 15 54
CI 15 824 251 900 40 58 Atripla 11 31
CI 16 617 24 1,272 40 157 Kivexa-Efavirenz 3 54
CI 17* 776 407 478 40 289 Atripla 231 24
CI 18 277 228 909 40 11 Complera 2 23
CI 19 459 n.a 545 40 215 n.a. n.a. 48
Median 592 230 538 40 156 Yes 105 47
1, cells/μl; 2, HIV RNA copies per ml plasma (log10);
3, months; ART, antiretroviral therapy; 4, months post-infection; 5, years; n.a., information not available on ART
duration and regimen; *, subject infected at birth.
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Figure 1 Phenotypically naive CD4+ T-cells from CI on ART subjects are impaired in their Th17-polarization potential in vitro. Total CD4+ T-cells
were isolated by negative selection using magnetic beads (Miltenyi) and stained with a cocktail of CD8, CD19, CD56, CD45RA, and CCR7 Abs and
the viability dye Vivid. (A) Shown is the schematic experimental design. Briefly, naive-like CD4+ T-cells (CD45RA+CCR7+ phenotype) lacking CD8,
CD19, and CD56 expression, were sorted by flow cytometry (as in Additional file 1: Figure S1) and stimulated via CD3/CD28 under Th17 polarizing
conditions for 12 days. Media containing polarizing cytokines and Abs together with IL-2 was refreshed at day 4 and 8 post-culture. At day 12,
cells were stimulated with PMA and Ionomycin in the presence of Brefeldin A for 17 hours. Cells were analyzed by flow cytometry for cytokine
expression upon intracellular staining with specific Abs. Vivid-positive cells were excluded from the analysis. (B) Shown is the frequency of cells
expressing intracellular IL-17A, IFN-γ, and/or TNF-α in representative HIV- control and CI on ART subject. (C-D) Shown are statistical analysis of
single cytokine expression (C) and cytokine co-expression (D) in Th17-polarized cells from HIV- controls (n = 8) and CI on ART (n = 10) subjects.
(E-F) At day 8 of polarization cell pellets and culture supernatants were harvested for the quantification of RORC mRNA (n = 3 HIV- and n = 5 CI
on ART) and IL-17A production (n = 6 HIV- and n = 6 CI on ART), respectively. The Mann Whitney p-values are indicated on the graphs. (G) Shown
is statistical analysis of cell viability. Each symbol represents a different subject. The Mann–Whitney p-values are indicated on the graphs. Clinical
parameters of subjects included in these studies are included in Table 1 (HIV- #03, 06, 07, 09, 14, 15, 19, 22) and Table 3 (CI #03, 04, 06–10, 16–18).
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tical analysis demonstrated a significant decrease in the
frequency of IL-17A+ but not IFN-γ+ or TNF-α+ cells
in CI on ART compared to HIV- controls (Figure 1C).
The analysis of IL-17A and IFN-γ co-expression dem-
onstrated a significant decrease in the frequency of IL-
17A+IFN-γ− (Th17 profile), IL-17A+IFN-γ+ (Th1Th17
profile) but not IL-17A−IFN-γ+ (Th1 profile) in CI on
ART compared to HIV- subjects (Figure 1D). These alter-
ations coincided with decreased expression of RORC
mRNA and a reduced production of IL-17A in culture su-
pernatants collected at day 8 of polarization (Figure 1E-F).
Alterations in the Th17 polarization potential in CI on
ART subjects were associated with minor but significant
alterations in the viability of Th17-polarized naive T-cells
when compared to HIV- controls (Figure 1G). A similar
Th17 polarization deficit was observed when experiments
were performed with naive CD4+ T-cells from HIV+ RI
patients (n = 5; data not shown). Finally, no significant dif-
ferences where observed between CI on ART and HIV-
controls regarding the Th1 polarization potential of naive
T-cells (median 12.9% (n = 10) versus 15.45% IFN-γ+ cells
(n = 4); Mann–Whitney p-value = 0.54; data not shown). Of
note, the frequency of IL-17A−IFN-γ+ was significantly
higher when naive T-cells from CI on ARTsubjects were cul-
tured under Th1 (IL-2 only) versus Th17 conditions (12.9%
versus 1.3%; median; n = 10; Wilcoxon p-value = 0.001; data
not shown), consistent with the well-established inhibition of
Th1 polarization under Th17 conditions [33-35,56].
Together, these results provide evidence that pheno-
typically naive CD4+ T-cells from HIV+ subjects are im-
paired in their differentiation and survival potential in
response to Th17- but not Th1-polarizing signals. This
deficit is observed in CI subjects despite an efficient con-
trol of viral replication under ART.
Phenotypically naive CD25highCD127−FoxP3+ and CD25+CD127+
FoxP3− T-cells preferentially acquire Th17 features in vitro
Previous studies demonstrated that Th17 cells differentiate
from naive CD4+ T-cells (defined as CD45RA+ cells) witha regulatory phenotype (nTregs: CD25highCD127−FoxP3+)
but not from conventional naive cells (nT: CD45RA
+CD25−CD127+FoxP3−) [35,50]. In addition to nTregs and
nT, the differential expression of CD25, CD127, and FoxP3
identifies two other phenotypically naive CD4+ T-cell sub-
sets with yet undocumented ability to undergo Th17
polarization: double positive (DP: CD25+CD127+FoxP3−)
and double negative (DN: CD25−CD127−FoxP3−) subsets
(Figure 2A). Here, we investigated the relative contribu-
tion of these four naive-like T-cell subsets to the pool of
Th17 cells in HIV-uninfected subjects. Flow cytometry-
sorted subsets (Additional file 2: Figure S2) were cul-
tured under Th17 polarizing conditions, as in Figure 1A.
Consistent with previous studies [35,50], Th17-polarized
nTregs generated the highest frequency of IL-17A-
expressing cells in vitro (Figure 2C-D). A significant
fraction of cells producing IL-17A in the presence (IL-
17A+IFN-γ+; Th1Th17 profile) or the absence of IFN-γ
(IL-17A+IFN-γ−; Th17 profile) also originated from DP
cells (Figure 2C-D). Consistent with other studies
[33,34,54], a subset of Th17-polarized nTregs but also
DP cells acquired Th1 features (IL-17A−IFN-γ+) when
cultured under Th17 polarizing conditions (Figure 2C-D).
Finally, IL-17A+ cells also differentiated from Th17-
polarized nT and DN cells, although their frequency was
significantly lower compared to nTregs (Figure 2C-D).
Together, these results emphasize the phenotypic hetero-
geneity of phenotypically naive CD4+ T-cells in terms of
Th17 polarization potential and identify nTregs and DP
cells as being relatively enriched in Th17 lineage-
committed cells.
The frequency of nTregs and DP cells is reduced in
HIV-infected subjects receiving ART
We further investigated whether the Th17 polarization
deficit in HIV-infected subjects was associated with the
paucity of nTregs and DP cells. To this aim, we quanti-
fied the frequency/counts of total naive CD4+ T-cells
and subsets expressing a nTreg and DP phenotype in
the peripheral blood of CI on ART (n = 18), RI subjects
Figure 2 Phenotypically naive CD25highCD127−FoxP3+ and CD25+CD127+FoxP3− T-cells preferentially differentiate into Th17 cells. PBMCs from
HIV- controls were stained with a cocktail of CD3, CD4, CD45RA, CCR7, CD25 and CD127 Abs on the surface and intracellularly with FoxP3 Abs. (A) The
differential expression of CD25 and CD127 distinguished four CD45RA+CCR7+ CD4+ T-cells subsets: CD25highCD127− (nTregs), CD25−CD127+ (nT,
conventional), CD25+CD127+ (DP, double positive) and CD25−CD127− (DN, double negative). (B) Shown is the expression of FoxP3 on these four
subsets. (C-D) The four CD45RA+CCR7+ T-cell subsets were sorted by flow cytometry as in Additional file 2: Figure S2, stimulated via CD3/CD28,
and cultivated under Th17 polarizing conditions and assessed for the co-expression of IL-17A and IFN-γ as in Figure 1. Vivid staining was used to
exclude dead cells. (A-C) Results are from one donor representative of experiments performed with cells from n = 4 donors. (D) Shown are statistical
analysis of Th17-polarized nTregs (n = 4), nT (n = 4), DP (n = 3), and DN cells (n = 3) with differential expression of IL-17A and IFN-γ. Paired t-Test p-values
are indicated on the graph. Clinical parameters of subjects included in these studies are included in Table 1 (HIV- # 3, 5, 6, 15).
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of total naive CD4+ T-cells, nTregs and DP cells were
calculated taking into account clinical CD4 counts andthe frequency of cell subsets within the CD4+ T-cell pool
determined by flow cytometry analysis ex vivo. A statisti-
cally significant decrease in the frequency and/or counts
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ART and/or RI compared to HIV- controls (Figure 3A),
indicative that these HIV-infected subjects were im-
munologically compromised. Similar observations were
made when the frequency and counts of nTregs, DP, and
CD25+ T-cells (including both nTregs and DP cells)
were compared in CI on ART and RI subjects versus
HIV- controls (Figure 3B-D). A modest but significant
increase of DP but not nTreg counts was observed in CI
on ART versus RI subjects (Figure 3B-C), suggesting a
positive effect of ART on DP cell restoration. Finally, we
demonstrate a positive correlation between the yield of
Th17 differentiation in vitro and the frequency of pheno-
typically naive nTregs and total CD25+ T-cells (Additional
file 3: Figure S3). Together, these results reveal severe
quantitative alterations within naive CD4+ T-cells, includ-
ing those with nTreg and CD25+ phenotypes, in the per-
ipheral blood of HIV-infected subjects despite viral
suppressive ART. These alterations likely contribute to
the impaired Th17 polarization observed in vitro.
The paucity of nTregs and DP cells in CI on ART subjects
is associated with decreased proportions of memory Th17
and Tregs
Previous studies documented the developmental and func-
tional relationship between Th17 and Tregs [51,52] and
profound alterations of these two lineages during progres-
sive HIV/SIV infections [9,13]. Therefore we investigated
whether the Th17 polarization deficit and the paucity of
nTregs and DP cells (Figures 1 and 3; Additional file 3:
Figure S3) observed in our patient cohorts (Tables 1-3) are
associated with alterations in the pool of memory
(CD45RA−) Th17 (mTh17) and Tregs (mTregs). To func-
tionally identify mTh17 cells, we first quantified the co-
expression of IL-17A and IFN-γ in memory CD4+ T-cells
upon PMA/Ionomycin stimulation in vitro. No intracellu-
lar cytokines were detected in the absence of stimulation
(data not shown). Results in Figure 4A-B illustrate a sig-
nificantly decreased frequency of IL-17A+IFN-γ− (Th17
profile) and IL-17A+IFN-γ+ (Th1Th17 profile) cells in CI
on ART subjects (n = 8) versus HIV- controls (n = 5), indi-
cative of an altered frequency of mTh17 cells. To investi-
gate the frequency of mTh17 cells in large cohorts of
HIV-infected subjects, we used the previously described
Th17 surface markers CCR6, CD26, and CD161 [57]. In
preliminary experiments, we validated that the majority of
IL-17A-producing cells exhibit a CCR6+CD26+CD161+
phenotype in both uninfected controls and CI on ART
subjects (Figure 4C-D). There was a positive correlation
between the frequency of CCR6+CD26+CD161+ and that
of IL-17A-producing cells (SC p = 0.04 and r = 0.9, n = 5;
data not shown). Despite the fact that only a minor frac-
tion of CCR6+ T-cells produce IL-17A ex vivo, CCR6+IL-
17A− but not CCR6− cells are prone to acquire Th17functions [58], thus justifying the use of these surface
markers to predicting the frequency of mTh17 [57,59,60].
The frequency and/or counts of mTh17, identified as in
Figure 4E, were significantly reduced in the peripheral
blood of CI on ART and RI subjects compared to HIV-
controls (Figure 4F). To establish a potential link between
the paucity of nTregs and DP cells and that of mTh17 cells,
SC and LR models were applied to study the correlation be-
tween the counts of these different subsets in HIV- controls
and CI on ART subjects. The counts of mTh17 cells were
positively correlated with the counts of nTregs, DP cells,
and also total CD25+ T-cells in CI on ART subjects
(Figure 4G). Similarly, memory Tregs (mTregs) identified
as cells with a CD45RA−CCR7+/−CD25highCD127−FoxP3+
phenotype (Additional file 4: Figure S4A-B) were signifi-
cantly depleted in frequency and/or counts in CI on ART
and RI versus HIV- subjects (Additional file 4: Figure S4C).
The counts of mTregs were positively correlated with the
counts of nTregs, DP cells, and also total CD25+ T-cells in
CI on ART (Additional file 4: Figure S4D). Thus, alterations
in the frequency and counts of nTregs and DP are associ-
ated with alterations in the pools of mTh17 and mTreg in
HIV-infected subjects.
NTregs and DP cells are preferentially infected in HIV-
infected subjects receiving ART
Because HIV-infection significantly contributes to CD4+
T-cell depletion [61-64], we investigated whether, among
phenotypically naive T-cells subsets, nTreg and DP cells
carry superior levels of integrated and/or non-integrated
forms of HIV-DNA in CI on ART subjects. Matched
nTregs, nT, DP, and DN cells, together with memory
CD45RA− CD4+ T-cells, were sorted by flow cytometry
(as in Additional files 1 and 2: Figure S1-S2) from five
CI on ART subjects. Integrated and Gag HIV-DNA was
detected at different levels in T-cell subsets of 5/5 sub-
jects (CI on ART subjects 4, 6, 8, 12, and 16; Table 3),
with the infection of CD45RA+CCR7+ T-cells being in-
ferior to that of memory CD45RA− T-cells (Figure 5A
and C). Then, levels of integrated and Gag HIV-DNA in
nTregs, DP, and DN cells were analyzed relative to con-
ventional nT cells (considered as 100%) in five CI on ART
subjects (Figure 5B and D). HIV-DNA integration oc-
curred at superior levels in nTregs versus nT (Figure 5B).
Also, levels of Gag HIV-DNA were significantly higher in
nTregs versus nT and DN cells (Figure 5D). In addition,
there was a tendency for superior Gag HIV-DNA levels in
DP versus nT cells from the 5/5 subjects, but results did
not reach statistical significance (Figure 5D). Thus, nTregs
and at a lower degree DP cells carried different forms of
HIV-DNA, indicative for a superior permissiveness to
HIV infection in these cells in vivo. To determine whether
the presence of HIV-DNA in CD45RA+CCR7+ nTregs
and DP cells was linked to a superior HIV entry, the
Figure 3 (See legend on next page.)
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Figure 3 Alterations in the frequency of phenotypically naive CD4+ T-cell subsets in HIV-infected subjects. PBMCs from HIV- controls and HIV-infected
subjects, RI and CI on ART, were analyzed for the frequency of total CD45RA+CCR7+CD4+ T-cells (naive-like) and with a CD25highCD127−FoxP3+ (nTregs)
or CD25+CD127+FoxP3− (DP) phenotype, together with the frequency and counts of total CD25+ T-cells. Cells were gated as in Figure 2. The viability
dye Vivid was used to exclude dead cells. (A-D) Shown are the frequency (left panel) and counts (right panel) of total naive-like (A), nTregs (B), DP cells
(C), and total CD25+ T-cells (D) in the peripheral blood of HIV- (n = 19), RI (n = 15) and CI on ART (n = 18) subjects. Each symbol represents a different
subject. The counts of CD45RA+CCR7+ subsets were calculated relative to their frequency and the CD4 counts. The Kruskal-Wallis and Dunns post-test
p-values are indicated on the graphs (*, p < 0.05; **, p < 0.01; ***, p < 0.001). Clinical parameters of subjects used in these studies are included in
Table 1(HIV- #01-03, 05, 07, 09–18, 20–23), Table 2 (RI# 1–15), and Table 3 (CI #01, 03–18).
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was analyzed in uninfected subjects. As expected,
CD45RA+CCR7+ T-cell subsets expressed lower CCR5
and higher CXCR4 levels compared to memory CD45RA−
T-cells, but no significant differences in CCR5 expres-
sion were observed between nTregs, DP and nT cells
(Figure 5E). In contrast, nTregs but not DP cells
expressed significantly lower levels of CXCR4 compared
to nT cells (Figure 5F). Together, these results suggest
that permissiveness to superior abortive and/or integra-
tive HIV infection, likely regulated at post-entry levels,
may represent one mechanism contributing to the de-
pletion of nTregs and DP cells in HIV-infected subjects.
Time of ART initiation and restoration of the Th17 deficit
during chronic HIV infection
Recent studies reported the benefit for early ART on im-
mune restoration in HIV-infected subjects [65-67]. To
determine whether the time of ART initiation impacts
on the frequency of phenotypically naive Th17 precur-
sors and mTh17 cells, we first studied the correlations
between the time of ART initiation and the counts of
nTreg and DP cells, and mTh17 cells in a group of CI
on ART subjects (Table 3). Results in Figure 6A illustrate
a significant negative correlation between the time of
ART initiation and the counts of nTregs (LR and SC)
and mTh17 (SC) but not DP cells. Of note, subjects with
history of slow (i.e., CI #03, 13, 17) and rapid (i.e., CI
#16, 18) disease progression were excluded for this ana-
lysis. The CD4+ T-cell counts were not correlated with
the time of ART initiation (data not shown), likely be-
cause ART is highly efficient in restoring CD4 counts in
the majority of subjects (median: 616 cells/μL; Table 2),
regardless of the restoration of CD4+ T-cells heterogen-
eity [21]. LR and SC models were further applied to de-
termine whether the size of the pool of nTregs and DP
cells and mTh17 cells in all available CI on ART subjects
can be predicted by the nadir CD4 counts before ART ini-
tiation. There was indeed a significant positive correlation
between the nadir CD4 counts and the counts of
nTregs, DP (LR and SC), and memory Th17 cells (SC
only) (Figure 6B). Finally, an early initiation of ART was
associated with reduced cell-associated Gag and inte-
grated HIV-DNA levels in memory CD4+ T-cells(Figure 6C). These results support a model in which early
ART initiation in HIV-infected subjects with relatively
high nadir CD4 counts permits a better restoration of the
Th17-lineage committed phenotypically naive subsets, to-
gether with mTh17 cells, likely via a robust control of
viral replication and persistence in these cells.
In addition to the above cross sectional studies, we
also performed a longitudinal analysis in four HIV-
infected subjects participating in our HIV primary infec-
tion (HPI) cohort, with an estimated time of infection
(ETI) <3 months and ART initiation within the first year
of infection (Table 4). We studied the dynamics of nTreg
and DP cell counts, together with the counts of mTh17
cells, in relationship with total CD4+ T-cell counts and
plasma viral load, at different time points post-inclusion
before and after ART initiation. ART resulted in a rapid
control of viral replication and immune restoration, as
reflected by undetectable plasma viral load (<50 HIV-
RNA copies/ml) and normalized CD4 counts, respect-
ively (Figure 7A). To determine the effect of ART on
nTreg, DP, and mTh17 cell restoration, these parameters
were compared before ART and at a time point after
ART initiation when the plasma viral load was undetect-
able for the second consecutive time. Despite donor-to-
donor variations in the dynamic of these three subsets
before and after ART, in all 4/4 donors the initiation of
ART led to a modest marginally significant increase in
the counts of nTregs, DP cells, mTh17 cells (Figure 7C).
Together, these transversal and longitudinal studies pro-
vide evidence that the time of ART initiation impacts on
the restoration/preservation of the pool of Th17-lineage
committed cells.
Discussion
In this manuscript, we provide evidence for the existence
of a new mechanism contributing to Th17 deficiency in
HIV-infected subjects. We demonstrate that phenotypic-
ally naive CD4+ T-cells from the peripheral blood of
chronically HIV-infected subjects with undetectable
plasma viral load under ART (CI on ART), as well as re-
cently HIV-infected viremics untreated (RI), are signifi-
cantly impaired in their ability to undergo Th17
polarization in vitro. In HIV- subjects, we reveal the ex-
istence of two phenotypically naive subsets enriched in
Figure 4 (See legend on next page.)
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Figure 4 Altered frequency of memory Th17 during HIV infection in relationship with the paucity of naive-like nTreg and DP cells. (A-D) Memory
CD4+ T-cells isolated by negative selection using magnetic beads (Miltenyi) were stimulated with PMA/Ionomycin and brefeldin A for 5 hours.
Shown are: (A) representative flow cytometry dot plots illustrating IL-17A and IFN-γ expression on CD3+CD8− T-cells from one HIV- and one CI on
ART; (B) statistical analysis of the frequency of IL-17A+IFN-γ− and IL-17A+IFN-γ+ cells in HIV- controls (n = 5; Table 1, HIV- #2, 10, 14, 31, 32) versus CI on
ART subject (n = 8; Table 3, CI #3, 7–11, 14, 18); (C) the co-expression of CCR6, CD26 and CD161 with IL-17A in one representative HIV- control; and
(D) statistical analysis for the frequency of IL-17A-expressing cells within CD3+CD8− T-cells co-expressing (+++) or lacking (—) CCR6, CD26, and
CD161. (E) Shown is the gating strategy for memory CD4+ T-cells (CD45RA−) with a mTh17 (CCR6+CD26+CD161+) phenotype in one representative
donor. (F) The frequency and counts of mTh17 cells were analyzed in HIV- (n = 18; Table 1, HIV- #1-3, 5, 9–18, 20–23), RI (n = 15, Table 2, RI 11–15),
and CI on ART (n = 17; Table 3, CI #1-12, 14–18) subjects. Each symbol represents a different subject. The (B) Mann–Whitney, (D) Wilcoxon, and
(F) Kruskal-Wallis and Dunns post test p-values are indicated on the graphs (*, p < 0.05; **, p < 0.01; ***, p < 0.001). (G) Linear regression (LR) and
Spearman correlation (SC) models were applied to determine the relationship between mTh17 cell counts and the counts of nTregs (left panel), DP
(middle panel) and total naive-like CD25+ T-cells (right panel) in CI on ART. LR p and r2 and SC p and r values are indicated on the graphs. For studies
in Figure 4G, subjects were identical to those included in Figure 4 F for which matched samples were available.
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sion of CD25 (IL-2 receptor alpha), CD127 (IL-7 recep-
tor alpha) and FoxP3 (Treg master regulator of
transcription): CD25highCD127−FoxP3+ (nTregs) and
CD25+CD127+FoxP3− (DP). In CI on ART, the paucity
of nTregs and DP cells coincided with the dramatic de-
pletion of memory cells producing IL-17A and/or ex-
pressing the Th17 markers CCR6, CD26, and CD161
(mTh17). Compared to conventional naive CD25− T-
cells (nT), nTregs and DP cells harbored superior levels
of HIV-DNA, suggesting that virus-induced cell death
contributes at least in part to their depletion in vivo.
Cross-sectional and longitudinal studies revealed that
early ART initiation and high nadir CD4 counts was as-
sociated with increased nTreg, DP, and mTh17 counts
and reduced HIV-DNA reservoirs. All together these
findings support a model in which the paucity of naive-
like subsets prone to acquire Th17 functions is caused at
least in part by their superior permissiveness to integra-
tive and/or abortive infection and represents a new pre-
viously unrecognized mechanism contributing to Th17
deficiency during HIV infection.
Molecular mechanisms of Th17 deficiency during
HIV/SIV infections remain a field of active investiga-
tions. Th17 deficiency in SIV-infected rhesus macaques
was recently associated with superior expression of sev-
eral negative regulators including the phosphatase SHP2,
the suppressor of cytokine signaling 3 (SOCS3), and the
protein inhibitor of activated STAT3 (PIAS3) [48]. These
inhibitory molecules were previously implicated in the
negative control of Th17 differentiation [68-70]. Consist-
ent with findings in an SIV infection model, in HIV-
infected subjects we report here profound alterations in
the ability of peripheral blood CD4+ T-cells expressing
the naive markers CD45RA and CCR7 [49] to survive
and undergo Th17 polarization in vitro. The recent dis-
covery of stem-cell memory T-cells (TSCM) that share
CD45RA and CCR7 expression with naive T-cells
[49,71,72], raises concerns on the phenotypic identifica-
tion of truly naive T-cells [33-35,54,55]. Since we cannotexclude the presence of TSCM in our pool of CD45RA
+CCR7+ cells, in this manuscript we use the term
“phenotypically naive” or “naive-like” T-cells. The Th17
polarization deficit was observed in both RI and CI on
ART HIV+ subjects. This is consistent with previous
studies by our group and others demonstrating a poor
restoration of mTh17 responses in subjects receiving
long-term ART [21,45,46,54]. Noteworthy, the ability of
Th17- or Th1-polarized naive-like T-cells from HIV-
infected subjects to produce IFN-γ was not affected, indi-
cating that the Th17 pathway was specifically altered dur-
ing HIV infection. Recent studies demonstrate that CD5
versus CD28 co-stimulation contributes to an enhanced
ability of naive CD4+ T-cells to undergo Th17 polarization
[56]. Also, treatment with recombinant IL-21 proved to be
beneficial for the maintenance of mucosal Th17 cells in
SIV-infected rhesus macaques [12,47]. Whether CD5 co-
stimulation and/or IL-21 supplementation could restore
the differentiation potential and improve survival of
Th17-linneage committed cells in HIV-infected subjects
deserves investigations.
Strong experimental evidence supports the reciprocal
differentiation relationship between Th17 cells and regu-
latory T-cells (Tregs), with Tregs being able to convert
into Th17 cells under inflammatory conditions [20,73].
Suppressive Tregs exhibit a CD25highCD127−FoxP3+
phenotype [74,75]. Differential expression of CD45RA
and CD45RO distinguishes between naive (nTregs) and
effector/memory (mTregs) Tregs [54,76]. Valmori et al.
reported first the existence of a peripheral blood pool of
Tregs (CD25+CTLA4+FoxP3+) exhibiting naive features
(CD45RA+CCR7+CD45RO−CD62L+) and suppressive
functions in vitro, similar to mTregs (CD45RA−CD45RO+)
[77]. They also demonstrated that levels of TRECs were
similarly high in nTregs and conventional naive T-cells
[77]. Studies by Seddiki et al., subsequently documented
the existence of nTregs in different human compartments
including thymus, cord and adult blood, lymph nodes and
spleen [78]. Further studies by Seddiki et al., identified
CD127 as a new marker distinguishing Tregs from
Figure 5 (See legend on next page.)
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Figure 5 nTregs and DP cells exhibit superior permissiveness to infection. Matched total memory (CD45RA−) and the four subsets of CD45RA
+CCR7+ CD4+ T-cells (nTregs, nT, DP, and DN cells) were isolated by flow cytometry from the PBMCs of CI on ART subjects as in Additional file 1
and 2: Figure S1-S2, respectively. Levels of integrated (A) and Gag (C) HIV-DNA were quantified by real-time PCR (equivalent of 105 cells/test in
triplicates) in matched samples from five CI on ART subjects (Table 3, CI #4, 6, 8, 12, 16). HIV-DNA copies were normalized to CD3 levels and
expressed as HIV-DNA copies/106 cells. (A, C) Shown are results from individuals donors. (B, D) Shown are statistical analysis of relative integrated
and Gag HIV-DNA levels in naive T-cell subsets (mean ± SD, n = 4); HIV-DNA levels in conventional naive cells (nT) were considered 100%. (E-F)
PBMCs from HIV-uninfected subjects (n = 17) were stained on the surface with CD3, CD4, CD45RA, CCR7, CD25, CD127, and CCR5 or CXCR4 Abs.
The viability dye Vivid was used to exclude dead cells. The nTregs, nT, and DP cells (identified as in Figure 2A), together with total memory CD4+
T-cells (identified as in Figure 4E), were analyzed for the expression of CCR5 and CXCR4. Shown are the frequencies of CCR5+ (E) and CXCR4+ (F) T-cells
within each subset of HIV-uninfected subjects (n = 17; Table 1, HIV- #1,2,5,10,14,15,18,20,21,23-30). The Friedman and Dunns’ post-test p-values are
indicated on the graphs (*, p < 0.05; **, p < 0.01; ***, p < 0.001).
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groups used this nomenclature for nTregs in humans
[35,50,54,76,79-84]. It was previously reported that a frac-
tion of human nTregs cultured under Th17 polarizing
conditions differentiate into IL-17A-producing cells ex-
pressing the Th17-specific transcription factor RORγt and
lacking suppressive activity in vitro [35,50]. In this con-
text, we hypothesized that HIV infection was associated
with alterations in the nTreg pool. We first confirmed
findings by other groups [35,50] that nTregs versus con-
ventional nT cells acquire IL-17A expression in vitro. In
addition, we identified naive-like DP T-cells (CD25
+CD127+FoxP3−) as a second source of IL-17A-producing
cells. The culture under Th17-polarizing conditions of
four naive-like subsets with differential expression of
CD25 and CD127 generated a heterogeneous population
of effector cells with Th17 (IL-17A+IFN-γ−), Th1Th17 (IL-
17A+IFN-γ+), and Th1 (IL-17A−IFN-γ+) profiles, consist-
ent with results by other groups [33,34,54]. We provide
evidence that Th17-polarized nTreg and DP versus con-
ventional CD25−CD127+ (nT) and CD25−CD127− (double
negative, DN) cells were enriched in IL-17A+IFN-γ− and
IL-17A+IFN-γ+ cells, indicative that fractions of nTreg
and DP are committed toward the Th17 lineage. Fractions
of Th17-polarized nTregs and DP also produce IFN-γ in
the absence of IL-17A, thus illustrating the functional het-
erogeneity of nTregs and DP pools that include both
Th17- and Th1-lineage committed cells.
The control of viral replication under ART is associ-
ated with the restoration of CD4 counts, but the hetero-
geneity and function of CD4+ T-cell subsets is not fully
restored [21]. Here we report a dramatic decrease in the
frequency/counts of nTregs and DP cells in the periph-
eral blood of CI on ART compared to HIV- subjects. A
similar decrease was observed when the frequency of
total naive-like CD25+ T-cells was studied. These alter-
ations were also observed in the peripheral blood of RI
viremic subjects. There was a tendency for increased fre-
quency of DP but not nTreg counts in CI on ART versus
RI subjects. Differences in the ability of ART to restore
DP but not nTreg counts are intriguing and require fur-
ther investigations.Recent studies by Mercer et al. demonstrated that naive-
like (CD45RO−) CD25+ T-cells differentiate into two dis-
tinct types of IL-17-producing cells: FoxP3+HELIOS−
(IL-17+ Tregs) and FoxP3−HELIOS− (conventional
Th17) [54]. The authors also reported a decreased fre-
quency of IL-17+ Tregs in ART-treated HIV-infected
subjects versus controls [54]. This is consistent with our
findings that the pool of mTh17 and mTregs (frequency
and counts) is significantly reduced in CI on ART versus
uninfected subjects. Whether the IL-17+ Tregs and con-
ventional Th17 cells described by Mercer et al. [54] ori-
ginate from distinct Th17-lineage committed precursor
pools, such as nTregs and DP cells we identified in this
manuscript, remains to be investigated. Of particular im-
portance, CD127 expression distinguishes DP from
nTregs and therefore these two Th17-lineage committed
pools highly likely differ in their dependency on IL-7.
CD127 is preferentially expressed on memory T-cells ex-
pressing the Th17 marker CCR6 [23] and IL-7 is known
to favor Th17 polarization [58]. Recent studies by our
group demonstrated the positive effects of IL-7 therapy in
restoring gut abnormalities in HIV-infected subjects [85].
Whether IL-7 enhances survival and Th17-polarization of
DP cells remains to be investigated.
HIV-infection per se significantly contributes to CD4+
T-cell depletion [61-64]. Naive compared to memory T-
cells are typically resistant to HIV infection [86,87].
However, viral entry by receptor-mediated endocytosis
was documented in naive CD4+ T-cells, with the viral
life cycle being restricted at different steps before the
completion of reverse transcription and/or integration
[88]. Most recently, naive CD4+ T-cells were documented
to carry HIV-DNA in individuals receiving ART [89,90].
In some studies, abortive infection was reported to lead to
T-cell depletion [62,64], while in others HIV-DNA inte-
gration was identified as a cause of virus-induced cell
death [63]. Therefore we hypothesized that depletion of
nTregs and DP cells was caused at least in part by their
permissiveness to HIV infection. Indeed, studies by other
groups demonstrated that nTregs express the HIV core-
ceptors CCR5 and CXCR4 and are permissive to HIV in-
fection in vitro and in HIV-infected subjects [89,91,92].
Figure 6 Effect of early ART initiation on the pool of nTregs, DP, and mTh17 cells. The nTregs, DP, and memory Th17 cells were phenotypically
identified as in Figure 2A-B and Figure 4E, respectively. CD4 counts in CI on ART subjects are listed in Table 2. (A) LR and SC models were applied
to determine the relationship between the time of ART initiation (months post-infection) versus nTreg counts (left panel), DP counts (middle panel), and
Th17 counts (right panel) in CI on ART subjects (n = 11; Table 3, CI #1, 4–7, 9–12, 14–15). (B) LR and SC models were applied to determine the relationship
between the nadir CD4 counts versus nTreg counts (left panel), DP counts (middle panel), and Th17 counts (right panel) in CI on ART subjects (n = 16;
Table 3, CI #1, 3–12, 14–18). (C) Levels of Gag and integrated HIV-DNA were quantified by real time PCR in total memory CD4+ T-cells sorted by FACS
as in Additional file 1: Figure S1 from CI on ART subjects (n = 11). LR and SC models were applied to determine the relationship between the levels of
Gag (left panel) and integrated (right panel) HIV-DNA versus the time of ART initiation (months post-infection) in CI on ART subjects (n = 11). LR p and
r2 values together with SC p and r values are indicated on the graphs.
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nTregs compared to conventional nT-cells harbor super-
ior levels of integrated and non-integrated HIV-DNA in
CI on ART subjects. We also observed a tendency for su-
perior integrated and non-integrated HIV-DNA levels in
DP versus nT-cells. These differences were not linked to
superior CCR5 and CXCR4 expression, suggesting that
post-entry mechanisms may favor permissiveness to infec-
tion in nTregs and DP cells.At mucosal level, SIV/HIV disease progression was
linked to an altered balance between Tregs and Th17
cells to the detriment of Th17 cells [9,93]. In our study,
the depletion of Th17-lineage committed nTregs and DP
cells in CI on ART and/or RI subjects coincided with a
significant decrease in the frequency and counts of both
mTh17 and mTregs identified using well-established
surface markers, together with a decreased frequency of
memory CD4+ T-cells expressing IL-17A upon short
Table 4 Clinical parameters of HIV-infected subjects included in the HIV primary infection (HPI) cohort
Subjects Visit # CD4 counts1 Plasma viral load2 Time since infection3 Time since inclusion3 ART
HPI 01 V1 430 35,303 2.5 0 No
V2 520 2,301 3 1 No
ART at 8 months since infection V3 450 24,845 3.5 2 No
V4 350 38,395 4 3 No
V8 310 681 9 7 Yes
V9 690 40 12 10 Yes
V11 690 40 21 16 Yes
V12 - 40 21.5 19 Yes
V13 650 40 24 22 Yes
V14 - - 27 25 Yes
HPI 02 V1 407 189,343 2.5 0 No
V2 430 173,044 3.5 1 No
ART at 9.5 months since infection V3 403 59,181 4 2 No
V7 396 81,037 6.5 4 No
V9 467 74 11.5 9 Yes
V10 496 50 13 11 Yes
V11 516 50 16 13 Yes
V12 567 50 20 17 Yes
HPI 03 V1 580 86,627 1.5 0 No
V2 540 37,335 2.5 1 No
ART at 11.5 months since infection V4 740 27,348 3 2 No
V5 730 20,076 3.5 3 No
V7 670 11,127 5.5 5 No
V8 530 26,574 7.5 7 No
V9 460 85,718 10.5 10 No
V10 380 664 13.5 13 Yes
V11 660 113 17 17 Yes
V12 640 40 20 19 Yes
V13 780 40 22 22 Yes
HPI 04 V1 240 29,981,000 1 0 No
V3 700 129,717 2 1 No
ART at 4.5 months since infection V4 340 76,626 2.5 2 No
V7 650 712 5.5 5 Yes
V11 670 40 16 15 Yes
V12 870 40 19 18 Yes
V13 830 40 22 21 Yes
V14 - - 25 24 Yes
1, cells/μL; 2, HIV-RNA copies per mL plasma (log10);
3, months; ART, antiretroviral therapy.
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counts positively correlated with the counts of naive-like
nTregs, DP, and CD25+ T-cells, consistent with a poten-
tial differentiation relationship between these cells. Simi-
larly, there was a positive correlation between mTreg
counts and the counts of nTregs, DP, and total CD25+
T-cells. These results support the concept that Tregsand Th17 cells represent alternative decision fates of
CD4+ T-cell differentiation [52,73,94]. Although the de-
pletion of mTh17 cells during SIV/HIV infections is well
documented, reports relative to nTreg/mTreg alterations
are controversial (reviewed in [81]). These controversies
may be explained by differences in the biological sam-
ples (peripheral blood versus mucosal biopsies), clinical
Figure 7 (See legend on next page.)
DaFonseca et al. Retrovirology  (2015) 12:38 Page 17 of 23
(See figure on previous page.)
Figure 7 Longitudinal analysis of nTregs, DP, and mTh17 cell dynamics in HIV-infected subjects. Four HIV-infected subjects participating to the HIV
Primary infection (HPI) cohort were analyzed longitudinally for the frequency and counts of nTregs, DP, and memory Th17 cells in the peripheral blood
in relationship with plasma viral load and CD4 counts. Cell subsets were phenotypically identified as in Figure 2A-B and Figure 4E. The counts of
nTregs, DP, and memory Th17 cells were calculated relative to their frequency and the CD4 counts. (A) Shown are the dynamics of CD4 counts (open
circles) and plasma viral load (open squares) before and after ART initiation (grey quadrant). (B) Shown are the dynamics of nTreg (filled circles), DP cell
(filled triangles) and memory Th17 counts (filled squares) before and after ART initiation (grey quadrant). The estimated time of infection (ETI) and the
nadir CD4 count for each subject are indicated on the graphs. (C) Shown is statistical analyses of nTreg (left panel), DP (middle panel), and mTh17 cell
counts (right panel) before and after ART. The “after ART” time points are indicated for each patient by a black arrow (A) and correspond to the second
time point of the patient visit when plasma viral load was undetectable (<50 HIV-RNA copies/ml). Each symbol represents a different subject. Wilcoxon
p-values are indicated on the graphs. Indicated in bold are median cell counts values before and after ART.
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ferent studies, and/or phenotypic characterization of
Tregs. In line with our findings, very recent studies by
Simonetta et al. [76] used CD25, CD127, and FoxP3 as
markers for Treg identification and demonstrated that
absolute numbers of both nTregs and mTregs are sig-
nificantly reduced in ART-treated HIV-infected subjects
[83]. Changes observed in the peripheral blood may [95]
or may not [27] mirror events occurring at mucosal
sites. Considering the fact that the frequency of nTregs
within the naive-like T-cell pool positively correlates
with the yield of Th17 polarization in vitro, nTregs may
be used as a surrogate marker to predict Th17 alter-
ations in HIV-infected subjects and remains to be
proved.
The thymic output is reduced in HIV-infected sub-
jects, with ART being able to restore in part these alter-
ations [96]. The thymic function decreases with age [97]
and HIV causes immune senescence and premature
aging [98]. Thus, the paucity of nTregs and DP cells may
be the consequence of an impaired generation of these
cells by the thymus. Alterations observed in our study
occurred despite insignificant age differences between
HIV-infected and uninfected subjects. Whether the pau-
city of naive Th17 precursors is indicative of premature
aging in HIV-infected subjects remains to be further in-
vestigated in larger cohorts. The expression of CD31, a
surrogate marker for thymic output [90,99], was signifi-
cantly higher on total CD45RA+CCR7+CD4+ T-cells,
nTregs and DP cells in CI on ART versus HIV- controls
(Additional file 5: Figure S5). This is consistent with re-
ports by other groups demonstrating an effort of the thy-
mus to compensate for lymphopenia under ART [90,100].
On a very positive note, in our cohort of CI on ART
subjects we observed that the counts of nTreg and
mTh17 were higher in subjects where ART was initiated
early versus late post-infection. Moreover, we observed
that nTregs, DP, and mTh17 counts were positively corre-
lated with the nadir CD4 counts before ART. As predicted
based on previous studies [87], the size of cell-associated
HIV-DNA load in memory CD4+ T-cells was lower in
subjects where treatment was initiated early and at rela-
tively high nadir CD4 counts. Indeed, early ART initiationaccelerates the decay of HIV reservoirs upon long-term
treatment [67]. Finally, in a longitudinal analysis of HIV-
infected subjects included in the Montreal HIV primary
infection cohort we observed that ART initiation during
the first year of infection tended to increase nTreg, DP,
and mTh17 counts. These results indicate that the time of
ART initiation and nadir CD4 counts in chronically HIV-
infected subjects impacts on the levels of Th17 deficit.
Conclusions
In this study, we (i) demonstrate that phenotypically
naive CD4+ T-cells with CD25highCD127−FoxP3+
(nTregs) and CD25+CD127+FoxP3− (DP) phenotypes are
enriched in Th17-lineage committed cells in uninfected
controls and (ii) provide evidence supporting a model in
which the paucity of naive-like Th17 precursors repre-
sents a new mechanism contributing to Th17 deficiency
in HIV-infected subjects. The depletion of Tregs and DP
cells may be the consequence of their permissiveness to
abortive and/or integrative infection. However, other
causes such as alterations in the thymic output, impaired
DC ability to induce Th17 polarisation [28,30], and/or lim-
ited Th17-specific growth factors (e.g., IL-21 [12,47]; IL-7
[85]), cannot be excluded. Early ART initiation [16,65-67],
treatment intensification with integrase inhibitors, to-
gether with other alternative therapeutic strategies aimed
at Th17 restoration/preservation, will be critical for im-
proving mucosal immunity during HIV infection.
Methods
Study population
HIV-infected and uninfected donors were recruited at
the Montreal Chest Institute, McGill University Health
Centre and Saint-Luc Hospital, Montreal, QC, Canada,
through the FRQ-S/AIDS and Infectious Diseases Network
(Québec, Canada). Tables 1-3 summarize immunological,
virological and clinical parameters of HIV-uninfected
controls (HIV-; n = 27) and HIV-infected subjects, re-
cently infected untreated viremics (RI, n = 15) and chron-
ically infected under ART (CI on ART; n = 19) included
in transversal studies. ART included a protease inhibitor,
a non-nucleoside reverse transcriptase inhibitor, and nu-
cleoside reverse transcriptase inhibitors (Table 3).
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followed up longitudinally are described in Table 4.
Plasma viral load was measured using the Amplicor HIV-
1 monitor ultrasensitive method (Roche, detection thresh-
old 50 HIV-RNA copies/ml plasma). The date of infection
was estimated using clinical and laboratory data as well as
patient history information. Peripheral blood mono-
nuclear cells (PBMC) (up to 1010 cells) were isolated by
gradient density centrifugation from leukapheresis or
whole blood and frozen as previously reported [21].
Ethics statement
This study using PBMC from HIV-infected and unin-
fected subjects was conducted in compliance with the
principles included in the Declaration of Helsinki and
received approval from the Institution Review Board of
the McGill University Health Centre and CHUM-
Research Centre. All subjects signed a written informed
consent for their participation to the study.
Antibodies and polychromatic flow cytometry analysis
The following fluorochrome-conjugated Abs were used
for polychromatic flow cytometry analysis: CD3-Pacific
Blue (UCHT1), CD4-Alexa700 (RPA-T4), CD45RA-APC-
Cy7 (HI100), CCR6-PE (11A9), CCR7-PE-Cy7 (3D12),
CD25-PE (M-A251), CD26-FITC (L272), CD127-AF647
(HIL-7R-M21), CD161-PE-Cy5 (DX12), IFNγ-Alexa 700
(B27), CCR5-PE (2D7), CXCR4-PE (12G5), and CD8-APC
H7 (SK1) (BD Pharmingen), CD45RA-APC eFluor780
(HI100), CD56-FITC (MEM188), IL-17A-PE (eBio64DEC17),
FoxP3-AF488 (PCH101), TNFα-Pacific Blue (Mab11), and
IL-17A-eFluor660 (eBio64CAP17) (eBioscience), CD8-FITC
(BW135/80), CD19-FITC (LT19) (Miltenyi), CCR7-PE
(150503) (R&D) and CD31-BV605 (WM59) (Biolegend). Cell
phenotype was analyzed by flow cytometry using the BD
LSRII cytometer and BD Diva software. A viability staining
Vivid (Invitrogen) was included in each staining cocktail
to exclude dead cells from our analysis. FACS analysis was
performed using the FlowJo software (©Tree Star, Inc.).
For multicolor analysis, all Abs were titrated for an opti-
mal noise/signal ratio and Abs cocktails were validated by
comparing single to multiple staining. Positivity gates were
placed based on fluorescence minus one (FMO), as previ-
ously described [21,101].
Magnetic (MACS) and fluorescence activated cell sorting
(FACS)
Total or memory CD4+ T-cells were sorted from frozen
PBMCs by negative selection using magnetic beads
(Miltenyi). Cell purity (typically >95%) was determined by
FACS analysis upon staining with CD3-PB, CD4-Alexa700,
and CD8-FITC Abs for total T-cell enrichment, together
with CD45RA-APC eFluor780 and CCR7-PeCy7 Abs for
memory T-cell enrichment. In some experiments (Figure 1),memory and naive subsets were sorted by FACS (BDAria
II) from total CD4+ T-cells upon staining with CD45RA-
APC-Cy7 (APC-eFluor-780) and CCR7-PE Abs and a
cocktail of FITC conjugated Abs to exclude CD8+ T-cells
(CD8), NK cells (CD56), and B cells (CD19). The sorting
gates were set on CD45RA− (memory) versus CD45RA
+CCR7+ (naive T-cells) as depicted in Additional file 1:
Figure S1. In other experiments (Figures 2 and 5), naive
CD4+ T-cells subsets with differential expression of CD25
and CD127 were sorted upon staining with the cocktail
above together with CD25-PE and CD127-AF647 Abs.
The sorting gates were set as depicted in Additional file 2:
Figure S2 using the FMOs controls, as previously de-
scribed [21,101]. The viability staining Vivid (Invitrogen)
was included in each staining cocktail to exclude dead
cells. The post-sort quality analysis indicated that sorted
subsets were in average >99% pure based on CD3, CD4
and CD45RA expression (Additional file 1 and 2: Figure
S1–S2). Sorting based on CD25/CD127 expression led to
a significant enrichment of naive T-cell subsets (>80%),
with the exception of CD25+CD127+ which were typically
>50% enriched (Additional file 2: Figure S2).Th17 polarization in vitro
Naive and memory T-cell subsets (106 cells/ml) sorted by
FACS were stimulated with immobilized CD3 and soluble
CD28 Abs (1 μg/ml) and cultured in RPMI 1640 media
supplemented with human recombinant IL-23 (50 ng/ml),
TGF-β (10 ng/ml), IL-1β (10 ng/ml), and IL-6 (50 ng/ml)
cytokines and neutralizing IL-4 (1 μg/ml) and IFN-γ Abs
(10 μg/ml) (R&D Systems) for 12 days. Media including
polarizing cytokines, Abs, and IL-2 (5 ng/ml) was
refreshed at day 4 and 8 post-culture. Cells were split at
day 4 and/or 8 post-culture for an optimal density 1-2x106
cells/well.Intracellular staining for flow cytometry analysis
Cells were stimulated with PMA (50 ng/ml) and Ionomycin
(1 μg/ml) in the presence of Brefeldin A (2 μg/ml) for 5 h
or 17 h. The intracellular expression of IL-17A, IFN-γ and
TNF-α was quantified by flow cytometry (BD LSRII) upon
staining with appropriate Abs using the Cytofix/Cytoperm
kit (BD Biosciences) according to the manufacturer’s proto-
cols. The intracellular expression of FoxP3 was quantified
using the Anti-Human Foxp3 Staining Set Alexa Fluor® 488
(eBioscience) according to the manufacturer’s protocol.ELISA quantification of IL-17A production
IL-17A levels in cell culture supernatants were quanti-
fied by a specific ELISA assay (eBiosciences) according
to the manufacturer’s protocol.
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Total RNA was isolated using RNeasy kit (Qiagen). The
quality (260/280 ratio) and quantity of RNA collected
were measured by a Pearl nanophotometer (Implen,
Munich, Germany). One step SYBR Green real-time RT-
PCR (Qiagen) was carried out in a LightCycler 480 II
(Roche) according to the manufacturer’s recommenda-
tions. The quantification of RORC mRNA relative to the
28S rRNA levels was performed as we previously de-
scribed [21]. Each RT-PCR reaction was performed in
triplicates.
Real-time PCR quantification of Gag and integrated HIV-
DNA
The quantification of Gag and integrated HIV-DNA was
performed as we previously described [21,87]. Briefly,
cells were digested in a proteinase K buffer (Invitrogen),
and 105 cells/15 μl lysate were used per amplification.
Integrated HIV-DNA was amplified first (12 cycles)
using two outward-facing Alu primers and one HIV LTR
primer tagged with a lambda sequence; the CD3 gene
was amplified in the same reaction. The HIV and CD3
amplicons were then amplified in separate reactions
(Light Cycler 480, Roche Diagnostics). The HIV-DNA
was amplified using a lambda-specific primer and an
inner LTR primer in the presence of two fluorescent
probes specific for HIV LTR. The CD3 DNA was ampli-
fied using inner primers and two fluorescent probes spe-
cific for CD3. Similarly, total HIV-DNA was quantified
using two sets of outward and inner Gag primers
[21,87]. The sensitivity of the nested real-time PCR was
3 copies Gag and integrated HIV-DNA, as previously de-
scribed [21,87]. Amplification reactions were carried out
with Light Cycler 480 Probe Master Mix (Roche) and
Taq Polymerase (Invitrogen). The ACH2 cells carrying
one copy of integrated HIV-DNA per cell (NIAIDS re-
agent program) were used as standard curve.
Statistical analysis
All statistical analyses were performed using the GraphPad
Prism 5 software and details are included in Figure legends.
Additional files
Additional file 1: Figure S1. Flow cytometry sorting of CD4+ T-cell subsets.
Total CD4+ T-cells were isolated from PBMCs by negative selection using
magnetic beads (Miltenyi). Cells were stained with a cocktail of
CD45RA, CCR7, CD8, CD19, and CD56 Abs. The viability marker Vivid was
used to exclude dead cells. Naive-like (CD45RA+CCR7+ phenotype) and
memory (CD45RA−CCR7+/− phenotype) CD4+ T-cells lacking CD8, CD19,
and CD56 expression were sorted by flow cytometry. Shown is the phenotype
of cells before and after cell sorting by MACS and then FACS. Results were
generated with cells from one donor representative of experiments performed
with cells from different HIV-infected (n = 10) and uninfected donors (n = 8).
The purity of MACS and FACS sorted T-cells is indicated in the Figure as the %
of cells exhibiting a specific phenotype.Additional file 2: Figure S2. Flow cytometry sorting of phenotypically
naive CD4+ T-cells with differential expression of CD25 and CD127. Total
CD4+ T-cells were isolated from PBMCs by negative selection using
magnetic beads (Miltenyi). Cells were stained with a cocktail of CD3, CD4,
CD45RA, CCR7, CD25, and CD127 Abs and the viability dye Vivid. Viable
(Vivid−) naive-like (CD45RA+CCR7+) CD4+ T-cells with a CD25+CD127− (nTregs),
CD25−CD127+ (conventional nT), CD25+CD127+ (DP, double positive), and
CD25−CD127− (DN, double negative) phenotype were sorted by flow
cytometry. Shown are results from one donor representative of experiments
performed with cells from n = 3 HIV- controls and n = 5 CI on ART subjects.
The purity of MACS and FACS sorted T-cells is indicated on the Figure as the
% of cells exhibiting a specific phenotype.
Additional file 3: Figure S3 The frequency of nTregs and CD25+ T-cells
predicts the yield of Th17 polarization in vitro. Spearman correlation (SC)
and linear regression models (LC) were applied to determine the relationship
between the frequency of nTregs, DP, and CD25+ T-cells ex vivo (as described
in Figure 3) and the ability of phenotypically naive CD4+ T-cells to acquire
Th17 functions upon polarization in vitro (as described in Figure 1). Results
are from matched HIV- controls (n = 7; filled circles) and CI on ART subjects
(n = 10; filled triangles). Subjects were identical to those included in Figure 1C-G
for which matched samples were available.
Additional file 4: Figure S4 Altered frequency of mTregs during HIV
infection in relationship with the paucity of nTreg and DP cells. PBMCs from
HIV-infected, RI and CI on ART, and uninfected subjects were stained with a
cocktail of CD3, CD4, CD45RA, CCR7, CD25, and CD127 Abs on the surface
and with FoxP3 Abs intracellular, and analyzed by flow cytometry. CD45RA
+CCR7+ nTregs and DP cells were identified as in Figure 2A. (A) Shown is
the gating strategy for the identification of memory (CD45RA−) T-cell subsets
with a CD25highCD127− surface phenotype specific for memory Tregs
(mTregs). (B) Shown is the intracellular expression of FoxP3 in CD25highCD127−
versus CD25−CD127+ subsets. (A-B) Results are from one donor representative
of results generated with cells from n= 18 CI on ART and n = 18 uninfected
subjects. (C) The frequency (left panel) and counts (right panel) of mTregs
were analyzed in HIV- (n = 18) and CI on ART (n = 18) subjects. Each symbol
represents a different subject. The Kruskal-Wallis and Dunns post test p-values
are indicated on the graphs (*, p < 0.05; **, p < 0.01; ***, p < 0.001). (D) Linear
regression (LR) and Spearman correlation (SC) models were applied to
determine the relationship between mTreg counts and the counts of
nTregs (left panel), DP cells (middle panel) and total naive-like CD25+ T-cells
(right panel) in CI on ART subjects. LR p and r2 values together with SC p
and r values are indicated on the graphs. Clinical parameters of subjects used
for studies in Additional file 4: Figure S4C are included in Table 1 (HIV- #1-3, 5,
7, 9–18, 20–23), Table 2 (RI# 1–15), and Table 3 (CI #1, 3–18). For studies in
Additional file 4: Figure S4D, subjects were identical to those included in 4C,
except those for which CD4 counts were not available.
Additional file 5: Figure S5 Expression of CD31 on nTregs and DP cells
in CI on ART versus uninfected subjects. PBMCs from HIV-uninfected and
HIV-infected CI on ART subjects were stained on the surface with CD3,
CD4, CD45RA, CCR7, CD25, CD127 and CD31 Abs. The viability dye Vivid
was used to exclude dead cells. (A) Shown are the frequencies of CD31+
cells on total naive-like (CD45RA+CCR7+) CD4+ T-cells, nTregs, and DP
cells from HIV- controls versus CI on ART subjects. The Mann–Whitney
p-values are indicated on the graphs. (B) Shown is the analysis of the
relationship between the counts of total naive-like CD4+ T-cells, nTregs,
and DP cells and the frequency of CD31+ cells in each subset. LR p and
r2 values together with SC p and r values are indicated on the graphs.
Clinical parameters of subjects used for studies in this figure are included
in Table 1 (HIV- #1, 2, 5, 10, 14, 15, 18, 20, 21, 23–30) and 1C (CI #1-3, 6–19).
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